NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Luminate Medical

Luminate Medical

Private
IrelandHealthcare & Life Scienceshttps://www.luminatemed.com/

Last Round

Series A

Extension

Jan 7, 2026

Est. Valuation

$78M

Total Funding Raised

$68.94M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Luminate Medical is a medical technology company that develops wearable devices and services to prevent chemotherapy side effects and enable at-home cancer care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical devicechemotherapy side effectsscalp coolinghair loss preventioncold capsupportive oncologyhome infusionwearable medical deviceoncology technologypatient quality of lifeat-home chemotherapymedtechclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Luminate Medical Comps

Public and private peers based on sector, stage, and business model.

Luminate Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Luminate Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 7, 2026
GrantApr 23, 2025
Series A ExtensionDec 4, 2024
Series ASep 19, 2024
GrantNov 23, 2023
Grant
Jun 20, 2023

Key People

Founding team and executive leadership

Barbara Oliveira

Co-Founder Chief Clinical Officer

Founding Team

Aaron Hannon

CEO Co-Founder

Founding Team

Conor Macken

Chief Financial Officer

Executive Team

Luminate Medical Investors

Notable investors and investment history

Luminate Medical investors
InvestorRounds
Atlantic Bridge CapitalSeries A Extension, Series A
European Innovation Council FundGrant
GaingelsSeries A
ARTIS VenturesSeries A Extension, Series A
Y CombinatorAccelerator, Series A Extension
Faber VenturesSeries A Extension, Series A, Seed
ElkstoneSeries A Extension, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 23, 2026

    Grew 24% QoQ, from 50 to 62 employees.

  • Apr 23, 2026

    Grew 16% QoQ from 51 to 59 employees.

Luminate Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Luminate Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Luminate Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersIreland
Employee Range63
Year Founded2018
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.